Surgalign 

$0.02
41
+$0+0% Monday 19:49

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

9MayExpected
Q3 2022
Q4 2022
Q1 2023
Q2 2023
Q3 2023
Q4 2023
Q1 2024
-1.97
-1.31
-0.66
-0
Expected EPS
N/A
Actual EPS
N/A

Financials

-66.61%Profit Margin
Unprofitable
2019
2020
2021
2022
81.98MRevenue
-54.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow SRGAQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

About

Surgalign Holdings, Inc., a medical technology company, develops, manufactures, distributes, and markets spine implants worldwide. It offers products for thoracolumbar procedures, including Streamline TL Spinal Fixation system, a system for degenerative and complex spine procedures; and Streamline MIS Spinal Fixation system, a range of implants and instruments used via a percutaneous or mini-open approach; and interbody fusion devices, as well as products for cervical procedures, such as CervAlign ACP system, a comprehensive anterior cervical plate system; Fortilink-C IBF system, a cervical interbody fusion device that utilizes TETRAfuse 3D technology; and Streamline OCT system, a range of implants used in the occipito-cervico-thoracic posterior spine. The company also provides motion preservation systems comprising Coflex Interlaminar Stabilization device for the treatment of moderate to severe lumbar spinal stenosis in conjunction with decompression; HPS 2.0 Universal Fixation system, a pedicle screw system used for posterior stabilization of the thoracolumbar spine; and SImmetry SI Joint Fusion system, a minimally invasive surgical implant system to decrease opioid use, pain, and disability. In addition, it develops Augmented Reality and Artificial Intelligence digital surgery platform to enable digital spine surgery. The company markets its products through independent spine and biomaterial distributors to hospitals, ambulatory surgery centers, and healthcare providers, as well as through direct sales force. The company was incorporated in 1997 and is headquartered in Deerfield, Illinois.
Show more...
CEO
Employees
231
Country
US
ISIN
US86882C2044
WKN
000A3DMKG

Listings

0 Comments

Share your thoughts

FAQ

What is Surgalign stock price today?
The current price of SRGAQ is $0.02 USD — it has increased by +0% in the past 24 hours. Watch Surgalign stock price performance more closely on the chart.
What is Surgalign stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Surgalign stocks are traded under the ticker SRGAQ.
What is Surgalign revenue for the last year?
Surgalign revenue for the last year amounts to 81.98M USD.
What is Surgalign net income for the last year?
SRGAQ net income for the last year is -54.61M USD.
How many employees does Surgalign have?
As of April 08, 2026, the company has 231 employees.
In which sector is Surgalign located?
Surgalign operates in the Manufacturing sector.
When did Surgalign complete a stock split?
Surgalign has not had any recent stock splits.